TrialBritish journal of haematology2020

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.

Chezi Ganzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.